0001289456-05-000002.txt : 20120628
0001289456-05-000002.hdr.sgml : 20120628
20050217071754
ACCESSION NUMBER: 0001289456-05-000002
CONFORMED SUBMISSION TYPE: SC 13G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20050217
DATE AS OF CHANGE: 20050217
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: MOLECULAR DIAGNOSTICS INC
CENTRAL INDEX KEY: 0000075439
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 364296006
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-18287
FILM NUMBER: 05622562
BUSINESS ADDRESS:
STREET 1: 900 NORTH FRANKLIN STREET
STREET 2: SUITE 210
CITY: CHICAGO
STATE: IL
ZIP: 60610
BUSINESS PHONE: 4078490290
MAIL ADDRESS:
STREET 1: 900 NORTH FRANKLIN STREET 1
STREET 2: SUITE 210
CITY: CHICAGO
STATE: IL
ZIP: 60610
FORMER COMPANY:
FORMER CONFORMED NAME: AMPERSAND MEDICAL CORP
DATE OF NAME CHANGE: 19990527
FORMER COMPANY:
FORMER CONFORMED NAME: BELL NATIONAL CORP
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: PACIFIC COAST HOLDINGS INC
DATE OF NAME CHANGE: 19830303
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Lantana Small Cap Growth LLC
CENTRAL INDEX KEY: 0001289456
IRS NUMBER: 900148196
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G
BUSINESS ADDRESS:
STREET 1: 100 GOOSE HILL ROAD
CITY: COLD SPRING HARBOR
STATE: NY
ZIP: 11724
BUSINESS PHONE: 631-367-6762
MAIL ADDRESS:
STREET 1: 100 GOOSE HILL ROAD
CITY: COLD SPRING HARBOR
STATE: NY
ZIP: 11724
SC 13G
1
dwlan3.txt
SCHEDULE 13G
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. )
Molecular Diagnostics
(Name of Issuer)
Common Shares
(Title of Class of Securities)
60851R104
(CUSIP Number)
------------------------------------------------------------------------------
NANCY WENNER
100 GOOSE HILL ROAD
COLD SPRING HARBOR, NY 11724
631-351-0295
------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
February 7, 2005
------------------------------------------------------------------------------
(Date of Event which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check
the following box [_].
Note: Schedules filed in paper format shall include a signed original
and five copies of the schedule, including all exhibits. See Rule 13d-7 for
other parties to whom copies are to be sent.
--------
(1) The remainder of this cover page shall be
filled out for a reporting person's initial
filing on this form with respect to the subject
class of securities, and for any subsequent
amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other
provisions of the Act (however, see the Notes).
CUSIP No. 60851R104 13D Page 2 of 4
- ----------------------------------------------------------------
1 NAME OF REPORTING PERSONS
IRS IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Lantana Small Cap Growth LLC 90-0148196
- ----------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)/ /
(b)/ /
- ----------------------------------------------------------------
3 SEC USE ONLY
- ----------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- ----------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES -6,619,311-
BENEFICIALLY ---------------------------------------
OWNED BY 6 SHARED VOTING POWER
EACH -0-
REPORTING ---------------------------------------
PERSON 7 SOLE DISPOSITIVE POWER
WITH -6,619,311-
---------------------------------------
8 SHARED DISPOSITIVE POWER
-0-
- ----------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
-6,619,311-
- ----------------------------------------------------------------
10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See
Instructions)
- ----------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.54%
- ----------------------------------------------------------------
12 TYPE OF REPORTING PERSON (See Instructions)
OO
- ----------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 60851R104 13D Page 3 of 4
ITEM 1. SECURITY AND ISSUER.
The title of the class of equity securities to which this statement relates is
common stock, $.001 par value (the "Common Stock") of Molecular Diagnostics
Inc., a Delaware corporation (the "Company"). The address of the principal
executive offices of the Company is 900 North Franklin Street, Suite 210,
Chicago ILL 60610.
ITEM 2. IDENTITY AND BACKGROUND.
This Schedule 13D is being filed by Lantana Small Cap Growth LLC (the
"Reporting Person"). The address of the principal place of business and
the principal executive office of the Reporting Person is 100 Goose
Hill Road, Cold Spring Harbor, NY 11724.
During the last five years, the Reporting Person has not (i) been convicted in
any criminal proceeding or (ii) been a party to any civil proceeding of a
judicial or administrative body of competent jurisdiction as a result of which
he was subject to any judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to, federal or
state securities laws or finding any violation with respect to such laws.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
The consideration used to acquire the Common Stock was the Reporting Person's
funds.
ITEM 4. PURPOSE OF TRANSACTION.
All of the shares of Common Stock reported herein were acquired for investment
purposes.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
(a) and (b)
As of the date hereof, the Reporting Person is deemed to beneficially own an
aggregate of 6,619,311 shares of Common Stock, representing approximately 6.54%
of the number of shares of Common Stock stated to be outstanding by the Company
in its Quarterly Report on Form 10-QSB filed November 17, 2004. The Reporting
Person has sole power to direct the vote and direct the disposition of these
shares of Common Stock.
(c)
Other than as set forth in this Report, the Reporting Person has not effected
any following transactions in the shares of the Company's equity securities
within the past 60 days:
(d)
Not applicable.
(e)
Not applicable.
CUSIP No. 60851R104 13D Page 4 of 4
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH
THE ISSUER.
Except as described herein, there are no contracts, arrangements, understandings
or relationships (legal or otherwise) between the person named in Item 2 hereof
and any person with respect to any securities of the Company, including but not
limited to transfer or voting of any other securities, finder's fees, joint
ventures, loan or option arrangements, puts or calls, guarantees of profits,
divisions of profits or loss, or the giving or withholding of proxies.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
NONE.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
Lantana Small Cap Growth LLC
by /s/ Nancy Wenner
----------------
Secretary
February 7, 2005
The original statement shall be signed by each person on whose behalf the
statement is filed or his authorized representative. If the statement is signed
on behalf of a person by his authorized representative (other than an executive
officer or general partner of the filing person), evidence of the
representative's authority to sign on behalf of such person shall be filed with
the statement, PROVIDED, HOWEVER, that a power of attorney for this purpose
which is already on file with the Commission may be incorporated by reference.
The name and any title of each person who signs the statement shall be typed or
printed beneath his signature.
ATTENTION. Intentional misstatements or omissions of fact constitute Federal
criminal violations (SEE 18 U.S.C. 1001.).